The inducing and inhibiting effects of sodium valproate in vivo on the biotransformation systems of xenobiotics in isolated rat hepatocytes

References

• Bonkowsky H. L., Sinclair P. R., Emery S., Sinclair J. F. Seizure management in acute hepatic porphyria: Risks of valproate and clonazepam. Neurology 1980; 30: 588–592
   PubMed Web of Science ®Google Scholar
• Carl G. F., De Loach C., Patterson J. Chronic sodium valproate treatment in the rat: toxicity versus protection against seizures induced by Indoclon. Neurochemistry 1986; 8: 41–45
   Google Scholar
• Cotariu D., Evans S., Zaidman J. L. Effect of sodium valproate on subcellular fraction enzymes in rat liver. Enzyme 1985; 34: 196–200
   PubMedGoogle Scholar
• De Wolff F. A., Peters A. C. B., Kempen G. M. J. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate. Neuropediatrics 1982; 13: 10–13
   PubMed Web of Science ®Google Scholar
• Dickens M., Parsons D. N. The effect of Lamotrigine, a novel anticonvulsant, upon hepatic drug metabolising enzyme systems in the rat and marmoset. The Proceedings of the International symposium on clinical and basic aspects of enzyme induction and inhibition. July, 5–61985. Essen, West-Germany, 35
   Google Scholar
• Dickinson R. G., Harland R. C., Ilias A. M. Disposition of valproic acid in the rat, dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. The Journal of Pharmacology and Experimental Therapeutics 1979; 211: 583–595
   PubMed Web of Science ®Google Scholar
• Furlanut M., Schiaulini P., Rizonni G. Possible enzymatic inhibition by valproate. International Journal of Clinical Pharm. Res 1982; 2: 269–272
   Google Scholar
• Goldstein A. Correlation. Biostatistics, an Introductory Text, A. Goldstein. The Macmillan Company, New York 1968; 144–146
   Google Scholar
• Graf R., Gossrau R., Merker H. J., Schwabe R., Stahlmann R., Nau H. Enzyme cytochemistry combined with electron microscopy, pharmacokinetics and clinical chemistry for the evaluation of the effects of steady-state valproic acid concentrations on the mouse. Histochemistry 1985; 83: 347–358
   PubMedGoogle Scholar
• Habig W. H., Pabst M. J., Jakdsy. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry 1974; 249: 7130–7138
   PubMed Web of Science ®Google Scholar
• Heinemeyer G., Nau H., Hildebrandt A. G., Roots I. Oxidation and glucuronidation of valproic acid in male rats. Influence of phenobarbital, 3-methylcholanthrene, b-naphtoflavone and clofibrate. Biochemical Pharmacology 1985; 34: 133–139
   PubMed Web of Science ®Google Scholar
• Jäger E., Rating D., Platzek T., Helge H. Induction of drug metabolism by antiepileptic drugs. Epilepsia 1980; 21: 196
   Web of Science ®Google Scholar
• Jordan B. J., Shillingford J. S., Steed K. P. Preliminary observations on the protein binding and enzyme inducing properties of sodium valproate. Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, N. J. Legg. MCS consultants, England 1976; 112–116
   Google Scholar
• Kapetanovic I. M., Kupferberg H. J., Porter R. J., Theodore W., Schilman E., Penry J. K. Mechanism of valproate-phenobarbital interaction in epileptic patients. Clinical Pharmacology and Therapeutics 1981; 29: 480–486
   PubMed Web of Science ®Google Scholar
• Kesterson J. W., Granneman G. R., Machinist J. M. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 1984; 4: 1143–1152
   PubMed Web of Science ®Google Scholar
• Kremers P., Beaune P., Gielen J. Multiplicity of cytochrome P-450 monooxygenase in human liver. Naunijn-Schmiedeberg's Archives of Pharmacology 1985, Suppl. vol 330: R5
   Google Scholar
• Levy R. H., Koch K. M. Drug interactions with valproic acid. Drugs 1982; 24: 543–546
   PubMed Web of Science ®Google Scholar
• Levy R. H., Moreland T. A., Morselli P. L., Guyot M., Brachet-Liermain A., Loiseau P. Carbamazepine/Valproic acid interaction in man and rhesus monkey. Epilepsia 1984; 25: 338–345
   PubMed Web of Science ®Google Scholar
• Loiseau P., Brachet A., Henry P. Concentration of dipropylacetate in plasma. Epilepsia 1975; 16: 609–615
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randal R. J. Protein measurement with the folin phenol reagent. Biological Chemistry 1951; 193: 265–275
   Web of Science ®Google Scholar
• Nau H., Zierer R. Pharmacokinetics of valproic acid and metabolites in mouse plasma and brain following constant-rate application of the drug and its unsaturated metabolite with an osmotic delivery system. Biopharmaceutics and Drug Disposition 1982; 3: 317–328
   PubMed Web of Science ®Google Scholar
• Nau H., Zierer R., Spielmann H., Neubert D., Gansau C. A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sciences 1981; 29: 2803–2814
   PubMed Web of Science ®Google Scholar
• Oesch F., Jerina D. H., Daly J. A radiometric assay for hepatic epoxide hydrase activity with ‘7-3H’styrene oxide. Biochimica et Biophysica Acta 1971; 227: 685–691
   PubMed Web of Science ®Google Scholar
• Oxley J., Hedges A., Makki K. A., Monks A., Richens A. Lack of hepatic enzyme inducing effect of sodium valproate. British Journal of Clinical Pharmacology 1979; 8: 189–190
   PubMed Web of Science ®Google Scholar
• Patel I. H., Levy R. H., Cutler R. E. Phenobarbital-valproic acid interaction. Clinical Pharmacology and Therapeutics 1980; 27: 515–521
   PubMed Web of Science ®Google Scholar
• Perrier L., Lusseau D. Action inductrice ou inhibitrice de l'acide valproique sur les systèmes enzymatiques impliqués dans le metabolisme des xenobiotiques. Rapport scientifique et technique de Sanofi. 1984, personal communication of unpublished work
   Google Scholar
• Perucca E., Hedges A., Makki K. A., Ruprah M., Wilson J. F., Richens A. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. British Journal of Clinical Pharmacology 1984; 18: 401–410
   PubMed Web of Science ®Google Scholar
• Rogiers V., Vandenberghe Y., Vercruysse A. Inhibition of gluconeogenesis by sodium valproate and its metabolites in isolated rat hepatocytes. Xenobiotica 1985; 15: 759–765
   PubMed Web of Science ®Google Scholar
• Rogiers V., Paeme G., Vercruysse A., Bouwens L. Procyclidine metabolism in isolated rat liver cells. Pharmacological, Morphological and Physiological Aspects of Liver Aging, C. F. A. Van Bezooijen. Eurage, Rijswijk 1984; 121–126
   Google Scholar
• Rogiers V., Adriaenssens L., Vandenberghe Y., Gepts E., Callaerts A., Vercruysse A. Critical evaluation of 7-ethoxycoumarin-O-deethylase activity measurement in intact isolated rat hepatocytes. Xenobiotica 1986; 16: 817–826
   PubMed Web of Science ®Google Scholar
• Sapeika N., Kaplan E. R. Effect of the antiepileptic drug sodium valproate on induction of hepatic microsomal P-450. Research Communications in Chemical Pathology and Pharmacology 1975; 10: 767–769
   PubMedGoogle Scholar
• Schobben F., Van Der Kleyn E., Gabreels F. J. M. Pharmacokinetics of di-n-propylacetate in epileptic patients. European Journal of Clinical Pharmacology 1975; 8: 97–105
   PubMed Web of Science ®Google Scholar
• Schoene B., Fleischmann R. A., Remmer H., Von Oldershausen H. F. Determination of drug metabolizing enzymes in needle biopsies of human livers. European Journal of Clinical Pharmacology 1972; 4: 65–73
   PubMed Web of Science ®Google Scholar
• Seidegard J., De Pierre J. W., Moron M. S., Johannesen K. A. M., Ernster L. Characterization of rat lung epoxide (styrene oxide) hydrase with a modified radioactive assay of improved sensitivity. Cancer research 1977; 37: 1075–1082
   PubMed Web of Science ®Google Scholar
• Siegel S. The case of two independent samples. Non-parametric Statistics for the Behavioral Sciences, S. Siegel. McGraw-Hill Kogakusha Ltd, Tokyo 1956; 116
   Google Scholar
• Suolinna E. M. Isolation and culture of liver cells and their use in the biochemical research of xenobiotics. Medical Biology 1982; 60: 237–254
   PubMedGoogle Scholar